لیشمانیاز (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "لیشمانیاز" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

2^nd place

195^th place

129^th place

doi.org

Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis". British medical bulletin. 104: 175–96. doi:10.1093/bmb/lds031. PMC 3530408. PMID 23137768.
Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy". Expert opinion on pharmacotherapy. 14 (1): 53–63. doi:10.1517/14656566.2013.755515. PMID 23256501.
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of antimicrobial chemotherapy. 67 (11): 2576–97. doi:10.1093/jac/dks275. PMID 22833634.
Minodier, P; Parola, P (May 2007). "Cutaneous leishmaniasis treatment". Travel medicine and infectious disease. 5 (3): 150–8. doi:10.1016/j.tmaid.2006.09.004. PMID 17448941.
Lozano, R (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert review of anti-infective therapy. 11 (1): 79–98. doi:10.1586/eri.12.148. PMID 23428104.

Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis". British medical bulletin. 104: 175–96. doi:10.1093/bmb/lds031. PMC 3530408. PMID 23137768.
Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy". Expert opinion on pharmacotherapy. 14 (1): 53–63. doi:10.1517/14656566.2013.755515. PMID 23256501.
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis". The Journal of antimicrobial chemotherapy. 67 (11): 2576–97. doi:10.1093/jac/dks275. PMID 22833634.
Minodier, P; Parola, P (May 2007). "Cutaneous leishmaniasis treatment". Travel medicine and infectious disease. 5 (3): 150–8. doi:10.1016/j.tmaid.2006.09.004. PMID 17448941.
Lozano, R (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects". Expert review of anti-infective therapy. 11 (1): 79–98. doi:10.1586/eri.12.148. PMID 23428104.

Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis". British medical bulletin. 104: 175–96. doi:10.1093/bmb/lds031. PMC 3530408. PMID 23137768.
«Leishmaniasis Kala-azar». ۳۱ مارس ۲۰۱۲. کاراکتر line feed character در |عنوان= در موقعیت 14 (کمک)

"Leishmaniasis Fact sheet N°375". World Health Organization. January 2014. Retrieved 17 February 2014.
"Leishmaniasis Magnitude of the problem". World Health Organization. Retrieved 17 February 2014.
«Leishmaniasis». دریافت‌شده در ۳۱ مارس ۲۰۱۲.